Trulieve Cannabis (TCNNF)
OTHER OTC:TCNNF

Trulieve Cannabis (TCNNF) Stock Forecast & Price Target

1,852 Followers
See the Price Targets and Ratings of:

TCNNF Analyst Ratings

Strong Buy
8Ratings
8 Buy
0 Hold
0 Sell
Based on 8 analysts giving stock ratings to
Trulieve
Cannabis
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

TCNNF Stock 12 Months Forecast

Average Price Target

$27.75
▲(124.97% Upside)
Based on 8 Wall Street analysts offering 12 month price targets for Trulieve Cannabis in the last 3 months. The average price target is $27.75 with a high forecast of $51.00 and a low forecast of $18.00. The average price target represents a 124.97% change from the last price of $12.34.
Highest Price Target$51.00Average Price Target$27.75Lowest Price Target$18.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Upgrade Banner
Alliance Global Partners
$25.65
Buy
107.97%
Upside
Reiterated
Trulieve Cannabis price target lowered to C$35 from C$40 at Alliance Global PartnersTrulieve Cannabis price target lowered to C$35 from C$40 at Alliance Global Partners
Haywood
$29.32
Buy
137.68%
Upside
Reiterated
Trulieve reported Q2/22 results that were in-line with our expectations on the top-line as well as adjusted EBITDA. The Company lowered its 2022 guidance by 5% at the low point, citing a number of factors. The impact of inflation on consumer spending, wholesale market pricing, and lack of forward visibility in the economy, as well as rationalizing activities and closing non-core assets were the factors leading to the revised guidance.
Roth Capital
$40.00
Buy
224.28%
Upside
Reiterated
Trulieve Cannabis Corp (TCNNF) PT Lowered to $40 at Roth CapitalRoth Capital analyst Scott FOrtune lowered the price target on Trulieve Cannabis Corp (OTC: TCNNF) to $40.00 (from $50.00) while maintaining a Buy rating.
ATB Capital Markets
$54.97
Buy
345.66%
Upside
Reiterated
Trulieve Cannabis has an Outperform rating with ATB CapitalATB Capital Markets analyst Kenric Tyghe sees a bit of upcoming turbulence with Trulieve Cannabis (Trulieve Cannabis Stock Quote, Chart, News, Analysts, Financials CSE:TRUL), though he maintained an Outperform rating and $75/share target price for a projected return of 178 per cent in an update to clients on Friday.
Beacon
$65.97
Buy
434.79%
Upside
Reiterated
Trulieve Cannabis is a screaming Buy, says Beacon SecuritiesBy Jayson MacLean Published on January 28, 2022 Last Updated on January 28, 2022 Filed under: All posts , Analysts , Cannabis Stock: trulTrulieve Cannabis is a screaming Buy, says Beacon Securities
Stocks with the Highest Top Analyst Consensus in the Basic Materials Sector
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
Find stocks in the Basic Materials sector that are highly recommended by Top Performing Analysts.

TCNNF Financial Forecast

TCNNF Earnings Forecast
Next quarter’s earnings estimate for TCNNF is -$0.08 with a range of -$0.23 to $0.09. The previous quarter’s EPS was -$0.61. TCNNF beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 51.76% of the time in the same period. In the last calendar year TCNNF has Underperformed its overall industry.
Next quarter’s earnings estimate for TCNNF is -$0.08 with a range of -$0.23 to $0.09. The previous quarter’s EPS was -$0.61. TCNNF beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 51.76% of the time in the same period. In the last calendar year TCNNF has Underperformed its overall industry.
TCNNF Sales Forecast
Next quarter’s sales forecast for TCNNF is $306.54M with a range of $293.00M to $316.50M. The previous quarter’s sales results were $287.27M. TCNNF beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 54.79% of the time in the same period. In the last calendar year TCNNF has Underperformed its overall industry.
Next quarter’s sales forecast for TCNNF is $306.54M with a range of $293.00M to $316.50M. The previous quarter’s sales results were $287.27M. TCNNF beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 54.79% of the time in the same period. In the last calendar year TCNNF has Underperformed its overall industry.
TCNNF Analyst Recommendation Trends
In the current month, TCNNF has received 1 Buy ratings 0 Hold ratings, and 0 Sell ratings. The TCNNF average analyst price target in the past 3 months is $27.75
In the current month, TCNNF has received 1 Buy ratings 0 Hold ratings, and 0 Sell ratings. The TCNNF average analyst price target in the past 3 months is $27.75

TCNNF Stock Forecast FAQ

What is TCNNF’s average 12-month price target, according to analysts?
Based on analyst ratings, Trulieve Cannabis’s 12-month average price target is $27.75.
    What is TCNNF’s upside potential, based on the analysts’ average price target?
    Trulieve Cannabis has 124.97% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is TCNNF a Buy, Sell or Hold?
          Trulieve Cannabis has a conensus rating of Strong Buy which is based on 8 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Trulieve Cannabis’s price target?
            The average price target for Trulieve Cannabis is $27.75. This is based on 8 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $51.00 ,the lowest forecast is $18.00. The average price target represents 124.97% Increase from the current price of $12.335.
              What do analysts say about Trulieve Cannabis?
              Trulieve Cannabis’s analyst rating consensus is a ‘Strong Buy. This is based on the ratings of 8 Wall Streets Analysts.

                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis